Thursday, July 2, 2020

Mylan Labs Gets Nod To Manufacture Remdesivir For COVID-19 Patients

The Drug Controller General of India (DCGI) has granted permission to Mylan laboratories to manufacture and market the anti-viral drug remdesivir for ''restricted emergency use'' on hospitalised...

from NDTV News - India-news https://ift.tt/3gyo74L
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Union Budget 2025: Expectations Of Indian Startups From Modi Government

With the Union Budget 2025 only a couple of weeks away, startups in the country are once again looking towards the Modi 3.0 administration ...